Using more exacting analytical tools can give a clearer assessment of gene-editing outcomes.
Marwan Alsarraj
Advertisement
Marwan Alsarraj is the Biopharma Segment manager at Bio-Rad.
Articles by Marwan Alsarraj
Standardization is needed in CAR-T cell therapy development due to its inherent complexity.
Advertisement
Latest Updated Articles
Assessing the Success of CRISPR Gene Therapies Using ddPCRPublished: May 3rd 2022 | Updated:
Advertisement
Advertisement
